banner
JAK inhibitor PRT 062070, Purity ≥98%
Inquiry

Cat. No.: X23-10-ZQ411

JAK inhibitor PRT 062070, Purity ≥98%

Synonym: Cerdulatinib; 1198300-79-6; Cerdulatinib (PRT062070); Cerdulatinib [INN]; PRT062070; UNII-D1LXQ45S1O; D1LXQ45S1O; JAK inhibitor

  • CAS Number: 1198300-79-6
  • Compound CID: 44595079
img
Product Size
10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
PRT 062070 is an available JAK small molecule inhibitor with potential antineoplastic activity. It targets AMPK, ARK5, CHK1, Flt3, Flt4, FMS, GCK, Itk, JAK1, JAK2, and JAK3.
Molecular Weight
445.54
Molecular Formula
C20H27N7O3S
Targets
AMPK: 6 nM; ARK5: 4 nM; CHK1: 42 nM; Flt3: 90 nM; Flt4: 51 nM; FMS: 5 nM; GCK: 18 nM; Itk: 194 nM; JAK1: 12 nM; JAK2: 6 nM; JAK3: 8 nM
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
PRT 062070 can be utilized to investigate the inhibition of JAK3 and other kinases.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0